ETROLIN-EP is a high-performance combination therapy featuring Etoricoxib and Pregabalin (Sustained Release), specifically designed to address the complexities of chronic pain management. As a signature product in the MK Healthcare portfolio, these tablets provide a dual-action approach by combining a potent non-steroidal anti-inflammatory drug (NSAID) with a neuropathic analgesic. This synergistic formulation is highly effective for patients suffering from conditions that involve both physical inflammation and nerve-related discomfort, such as severe sciatica, chronic back pain, and various forms of osteoarthritis.
The pharmacological strength of ETROLIN-EP lies in its ability to target pain from two different physiological pathways. Etoricoxib works as a selective COX-2 inhibitor to reduce the inflammation and swelling that cause joint and muscle pain, while the sustained-release Pregabalin modulates calcium channel activity to calm overactive nerve signals. This combination not only provides rapid relief from acute flares but also ensures long-lasting comfort throughout the day, helping patients restore their mobility and improve their overall quality of life without the need for frequent redosing.
To ensure the highest levels of safety and efficacy, MK Healthcare manufactures ETROLIN-EP in ISO and GMP-certified facilities located in the pharmaceutical hubs of Chandigarh and Himachal. The medication is presented in premium Alu-Alu packaging (10x10 Tablets), which serves as a superior barrier against environmental factors like moisture and oxidation. This careful attention to packaging ensures that the sustained-release properties of the Pregabalin and the chemical stability of the Etoricoxib remain intact until the point of consumption.
For pharmaceutical distributors and healthcare professionals, ETROLIN-EP represents a vital addition to any Neuro-care or Orthopedic product range. It is a high-demand formulation ideal for PCD pharma franchise opportunities and third-party manufacturing. By partnering with MK Healthcare for this product, distributors gain access to a scientifically backed, reliable treatment solution that meets the growing clinical need for comprehensive pain management. The brand?s strong presence in North India ensures a dependable supply chain for this essential therapeutic option.
